Go Pro

SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$3.28 +0.08 (+2.56%)
As of 09:42 AM Eastern
This is a fair market value price provided by Massive. Learn more.

ICU vs. SKYA, DRIO, ECOR, NYXH, and SNWV

Should you buy SeaStar Medical stock or one of its competitors? MarketBeat compares SeaStar Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SeaStar Medical include SkyAI, Inc. Common Stock (SKYA), DarioHealth (DRIO), electroCore (ECOR), Nyxoah (NYXH), and Sanuwave Health (SNWV).

How does SeaStar Medical compare to SkyAI, Inc. Common Stock?

SkyAI, Inc. Common Stock (NASDAQ:SKYA) and SeaStar Medical (NASDAQ:ICU) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat SkyAI, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
SkyAI, Inc. Common StockN/A -157.91% -154.40%
SeaStar Medical -828.62%-146.29%-96.48%

17.2% of SkyAI, Inc. Common Stock shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 1.2% of SkyAI, Inc. Common Stock shares are owned by insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

SeaStar Medical has higher revenue and earnings than SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SkyAI, Inc. Common Stock$200K272.96-$282.50M-$1.63N/A
SeaStar Medical$1.44M8.88-$12.15M-$4.80N/A

SkyAI, Inc. Common Stock has a beta of 2.06, indicating that its stock price is 106% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market.

SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 150.78%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts clearly believe SeaStar Medical is more favorable than SkyAI, Inc. Common Stock.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SkyAI, Inc. Common Stock
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, SkyAI, Inc. Common Stock had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 1 mentions for SkyAI, Inc. Common Stock and 0 mentions for SeaStar Medical. SkyAI, Inc. Common Stock's average media sentiment score of 1.74 beat SeaStar Medical's score of 0.00 indicating that SkyAI, Inc. Common Stock is being referred to more favorably in the media.

Company Overall Sentiment
SkyAI, Inc. Common Stock Very Positive
SeaStar Medical Neutral

Summary

SkyAI, Inc. Common Stock and SeaStar Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to DarioHealth?

DarioHealth (NASDAQ:DRIO) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, DarioHealth had 8 more articles in the media than SeaStar Medical. MarketBeat recorded 8 mentions for DarioHealth and 0 mentions for SeaStar Medical. DarioHealth's average media sentiment score of 0.64 beat SeaStar Medical's score of 0.00 indicating that DarioHealth is being referred to more favorably in the media.

Company Overall Sentiment
DarioHealth Positive
SeaStar Medical Neutral

DarioHealth presently has a consensus target price of $10.50, suggesting a potential upside of 47.89%. SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 150.78%. Given SeaStar Medical's higher probable upside, analysts plainly believe SeaStar Medical is more favorable than DarioHealth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DarioHealth
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

DarioHealth has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, suggesting that its share price is 205% less volatile than the broader market.

DarioHealth has a net margin of -192.23% compared to SeaStar Medical's net margin of -828.62%. DarioHealth's return on equity of -60.52% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
DarioHealth-192.23% -60.52% -37.08%
SeaStar Medical -828.62%-146.29%-96.48%

SeaStar Medical has lower revenue, but higher earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DarioHealth$21.19M2.46-$41.71M-$8.88N/A
SeaStar Medical$1.44M8.88-$12.15M-$4.80N/A

Summary

DarioHealth beats SeaStar Medical on 9 of the 14 factors compared between the two stocks.

How does SeaStar Medical compare to electroCore?

SeaStar Medical (NASDAQ:ICU) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 7.8% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market. Comparatively, electroCore has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market.

electroCore has a net margin of -44.08% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-828.62% -146.29% -96.48%
electroCore -44.08%-1,956.38%-83.30%

SeaStar Medical has higher earnings, but lower revenue than electroCore. electroCore is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.44M8.88-$12.15M-$4.80N/A
electroCore$32.03M1.72-$13.97M-$1.77N/A

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 150.78%. electroCore has a consensus price target of $18.00, indicating a potential upside of 195.57%. Given electroCore's higher possible upside, analysts plainly believe electroCore is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
electroCore
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, electroCore had 5 more articles in the media than SeaStar Medical. MarketBeat recorded 5 mentions for electroCore and 0 mentions for SeaStar Medical. electroCore's average media sentiment score of 0.59 beat SeaStar Medical's score of 0.00 indicating that electroCore is being referred to more favorably in the news media.

Company Overall Sentiment
SeaStar Medical Neutral
electroCore Positive

Summary

electroCore beats SeaStar Medical on 10 of the 14 factors compared between the two stocks.

How does SeaStar Medical compare to Nyxoah?

SeaStar Medical (NASDAQ:ICU) and Nyxoah (NASDAQ:NYXH) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

1.7% of SeaStar Medical shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SeaStar Medical has a beta of -1.05, suggesting that its stock price is 205% less volatile than the broader market. Comparatively, Nyxoah has a beta of 1.62, suggesting that its stock price is 62% more volatile than the broader market.

Nyxoah has a net margin of -543.21% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-828.62% -146.29% -96.48%
Nyxoah -543.21%-163.73%-80.24%

SeaStar Medical has higher earnings, but lower revenue than Nyxoah. SeaStar Medical is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.44M8.88-$12.15M-$4.80N/A
Nyxoah$11.33M4.99-$101.92M-$2.48N/A

SeaStar Medical currently has a consensus price target of $8.00, suggesting a potential upside of 150.78%. Nyxoah has a consensus price target of $5.96, suggesting a potential upside of 308.39%. Given Nyxoah's stronger consensus rating and higher possible upside, analysts plainly believe Nyxoah is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Nyxoah
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Nyxoah had 5 more articles in the media than SeaStar Medical. MarketBeat recorded 5 mentions for Nyxoah and 0 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.00 equaled Nyxoah'saverage media sentiment score.

Company Overall Sentiment
SeaStar Medical Neutral
Nyxoah Neutral

Summary

Nyxoah beats SeaStar Medical on 10 of the 15 factors compared between the two stocks.

How does SeaStar Medical compare to Sanuwave Health?

Sanuwave Health (NASDAQ:SNWV) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings, profitability and media sentiment.

Sanuwave Health currently has a consensus price target of $51.00, suggesting a potential upside of 708.24%. SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 150.78%. Given Sanuwave Health's stronger consensus rating and higher possible upside, research analysts clearly believe Sanuwave Health is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanuwave Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Sanuwave Health has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanuwave Health$44.05M1.23$11.81M$0.3319.12
SeaStar Medical$1.44M8.88-$12.15M-$4.80N/A

In the previous week, Sanuwave Health had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 1 mentions for Sanuwave Health and 0 mentions for SeaStar Medical. Sanuwave Health's average media sentiment score of 0.00 equaled SeaStar Medical'saverage media sentiment score.

Company Overall Sentiment
Sanuwave Health Neutral
SeaStar Medical Neutral

42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Comparatively, 0.7% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sanuwave Health has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market.

Sanuwave Health has a net margin of 35.96% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Sanuwave Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanuwave Health35.96% -450.56% 44.87%
SeaStar Medical -828.62%-146.29%-96.48%

Summary

Sanuwave Health beats SeaStar Medical on 13 of the 15 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$12.51M$5.66B$6.86B$12.43B
Dividend YieldN/A1.78%2.60%10.03%
P/E Ratio-0.6623.66280.7324.99
Price / Sales8.8858.68643.21112.42
Price / CashN/A32.5328.6434.82
Price / Book1.166.5110.946.21
Net Income-$12.15M$151.15M$3.48B$347.49M
7 Day Performance-7.27%3.18%0.78%1.28%
1 Month Performance-35.16%-1.01%-4.20%-3.62%
1 Year Performance-54.26%3.58%61.51%18.37%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
1.7695 of 5 stars
$3.28
+2.6%
$8.00
+143.8%
-51.3%$13.36M$1.44MN/A2
SKYA
SkyAI, Inc. Common Stock
0.5469 of 5 stars
$1.40
+6.1%
N/A-73.3%$55.87M$200KN/A55
DRIO
DarioHealth
3.7493 of 5 stars
$7.49
+0.3%
$10.50
+40.2%
-35.4%$54.84M$22.36MN/A200
ECOR
electroCore
2.7877 of 5 stars
$6.09
+0.7%
$18.00
+195.6%
-10.0%$54.55M$32.03MN/A50
NYXH
Nyxoah
2.3074 of 5 stars
$1.43
+2.1%
$5.96
+317.0%
-80.0%$54.26M$11.33MN/A110

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners